Porcilis Pesti

Nchi: Umoja wa Ulaya

Lugha: Kiingereza

Chanzo: EMA (European Medicines Agency)

Nunua Sasa

Taarifa za kipeperushi Taarifa za kipeperushi (PIL)
06-10-2011
Tabia za bidhaa Tabia za bidhaa (SPC)
06-10-2011

Viambatanisho vya kazi:

Classical Swine Fever Virus (CSFV) -E2 subunit antigen

Inapatikana kutoka:

Intervet International BV

ATC kanuni:

QI09AD04

INN (Jina la Kimataifa):

Adjuvanted vaccine against classical swine fever

Kundi la matibabu:

Pigs

Eneo la matibabu:

Immunologicals for suidae

Matibabu dalili:

Active immunisation of pigs from the age of 5 weeks onwards to prevent mortality and to reduce clinical signs of Classical Swine Fever, as well as to reduce infection with and excretion of CSF field virus.The onset of protection is 2 weeks.The duration of protection is 6 months.

Bidhaa muhtasari:

Revision: 12

Idhini hali ya:

Withdrawn

Idhini ya tarehe:

2000-06-09

Taarifa za kipeperushi

                                B. PACKAGE LEAFLET
14/17
PACKAGE LEAFLET
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE
MANUFACTURING
AUTHORISATION
HOLDER
RESPONSIBLE
FOR
BATCH
RELEASE, IF DIFFERENT
Intervet International B.V.
Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Porcilis Pesti emulsion for injection for pigs
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)
Each dose of 2 ml contains:
120 Elisa Units Classical Swine Fever Virus-E2 subunit antigen
Liquid paraffin as adjuvant: 941.4 mg
4.
INDICATION(S)
_ _
Active immunisation of pigs from the age of 5 weeks onwards to prevent
mortality and to reduce clinical
signs of Classical Swine Fever, as well as to reduce infection with
and excretion of CSF field virus.
The onset of protection is 2 weeks.
The duration of protection is 6 months.
5.
CONTRAINDICATIONS
None
6.
ADVERSE REACTIONS
A local and in most cases transient swelling at the injection site may
occur up to 4 weeks after administration
of each dose of the vaccine. Transient hyperthermia may occur post the
second dose.
Abscesses may be observed at the injection site.
Since safety after giving both inoculations at the same site
has not been examined, it is advised to carry out the second
vaccination at a different site than the first
vaccination.
If you notice any serious side effects or other effects not mentioned
in this leaflet, please inform your
veterinary surgeon.
7.
TARGET SPECIES
Pigs
15/17
8.
DOSAGE FOR EACH SPECIES, ROUTES AND METHOD OF ADMINISTRATION
Administer one dose (2 ml) by deep intramuscular injection in the neck
area behind the ear.
Vaccination scheme:
Basic vaccination: Inject one dose per pig followed by a second
injection 4 weeks after the first injection.
Re-vaccination: Every 6 months, using a single dose.
9.
ADVICE ON CORRECT ADMINISTRATION
Shake well before use.
Before use, allow the vaccine to reach room temperature.
Use sterile syringes and needles.
It is recommended to use a closed multiject vaccination system.
10.
WIT
                                
                                Soma hati kamili
                                
                            

Tabia za bidhaa

                                ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
1/17
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Porcilis Pesti emulsion for injection for pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose of 2 ml contains:
ACTIVE SUBSTANCE:
Classical Swine Fever Virus (CSFV) -E2 subunit antigen: 120 Elisa
Units (EU)
ADJUVANT:
941.4 mg liquid paraffin
EXCIPIENTS:
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Emulsion for injection.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Pigs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Active immunisation of pigs from the age of 5 weeks onwards to prevent
mortality and to reduce clinical
signs of Classical Swine Fever, as well as to reduce infection with
and excretion of CSF field virus.
The onset of protection is 2 weeks.
The duration of protection is 6 months.
_ _
4.3
CONTRAINDICATIONS
None
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Vaccinate only healthy animals.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO
ANIMALS
To the user:
2/17
This product contains mineral oil. Accidental injection/self injection
may result in severe pain and
swelling, particularly if injected into a joint or finger, and in rare
cases could result in the loss of the
affected finger if prompt medical attention is not given.
If you are accidentally injected with this product, seek prompt
medical advice even if only a very small
amount is injected and take the package leaflet with you.
If pain persists for more than 12 hours after medical examination,
seek medical advice again.
To the physician:
This product contains mineral oil. Even if small amounts have been
injected, accidental injection with this
product can cause intense swelling, which may, for example, result in
ischaemic necrosis and even the loss
of a digit. Expert, PROMPT, surgical attention is required and may
necessitate early incision and irrigation
of the injected area, especially where the
                                
                                Soma hati kamili
                                
                            

Nyaraka katika lugha zingine

Taarifa za kipeperushi Taarifa za kipeperushi Kibulgaria 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kibulgaria 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kibulgaria 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kihispania 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kihispania 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kihispania 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kicheki 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kicheki 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kicheki 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kidenmaki 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kidenmaki 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kidenmaki 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kijerumani 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kijerumani 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kijerumani 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kiestonia 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kiestonia 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiestonia 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kigiriki 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kigiriki 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kigiriki 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kifaransa 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kifaransa 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kifaransa 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kiitaliano 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kiitaliano 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiitaliano 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kilatvia 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kilatvia 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kilatvia 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kilithuania 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kilithuania 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kilithuania 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kihungari 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kihungari 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kihungari 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kimalta 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kimalta 06-10-2011
Taarifa za kipeperushi Taarifa za kipeperushi Kiholanzi 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kiholanzi 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiholanzi 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kipolandi 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kipolandi 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kipolandi 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kireno 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kireno 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kireno 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kiromania 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kiromania 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiromania 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kislovakia 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kislovakia 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kislovakia 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kislovenia 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kislovenia 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kislovenia 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kifinlandi 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kifinlandi 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kifinlandi 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kiswidi 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kiswidi 06-10-2011
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiswidi 26-02-2009
Taarifa za kipeperushi Taarifa za kipeperushi Kinorwe 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kinorwe 06-10-2011
Taarifa za kipeperushi Taarifa za kipeperushi Kiaisilandi 06-10-2011
Tabia za bidhaa Tabia za bidhaa Kiaisilandi 06-10-2011

Tazama historia ya hati